Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cytotoxicity Imaging

July 27, 2010 8:28 am | Product Releases | Comments

Genetix, a leading provider of solutions for imaging and image analysis, announces the availability of an independent, peer-reviewed publication comparing cytotoxicity testing using its CloneSelect Imager system against the conventional, widely-used, colorimetric MTT assay.

TOPICS:

Interaction Analysis

July 27, 2010 8:25 am | Drug Discovery & Development | Product Releases | Comments

GE Healthcare has launched the Biacore T200, designed to deliver exceptional sensitivity in the measurement of high-quality kinetic, affinity, concentration, specificity, and thermodynamic interaction data, in real time.

TOPICS:

AbD Serotec Signs Deal With University College London

July 27, 2010 8:08 am | News | Comments

AbD Serotec has signed an exclusive license agreement with University College London Business PLC to provide AbD Serotec with access to a potent anti-PTH antibody for commercial use in research and diagnostic applications.

TOPICS:
Advertisement

NovImmune to Supply Genentech With Antibodies

July 27, 2010 8:00 am | News | Comments

NovImmune, an antibody-focused research and development biotech company, has entered into an exclusive licensing agreement with Genentech Inc. for a proprietary anti-IL-17 fully human monoclonal antibody, and access to back-up antibodies.

TOPICS:

Herpes Protein Allows Cellular Invasion

July 27, 2010 7:54 am | News | Comments

The mechanism by which a herpes virus invades cells has always been a mystery to scientists, but now researchers have revealed that the unusual structure of a key member of the protein complex allows the herpes virus to enter cells.

TOPICS:

Key to Intensive Lupus Treatment Discovered

July 27, 2010 7:49 am | News | Comments

Researchers at UT Southwestern Medical Center have uncovered the biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus.

TOPICS:

FDA Approves TRIBENZOR

July 27, 2010 7:41 am | News | Comments

Daiichi Sankyo, Inc. announced that the U.S. Food and Drug Administration approved TRIBENZOR, a new three-in-one combination product taken once-daily for the treatment of hypertension.

TOPICS:

Cempra Completes Trial of Potent Antibiotic

July 27, 2010 7:32 am | News | Comments

Cempra Pharmaceuticals announced the successful completion of Phase 1 clinical trials of its oral formulation of CEM-101, which showed good tolerability in those studies.

TOPICS:
Advertisement

Study Investigates Importance of Fresh Blood

July 27, 2010 7:16 am | by Lauren Neergaard | News | Comments

Facing surgery? You could receive blood that's been stored for a week, or three weeks, or nearly six - and there's growing concern that people who get the older blood might not fare as well.

TOPICS:

Graphene Sheet Electrically Sequences DNA

July 27, 2010 7:11 am | News | Comments

Researchers at the University of Pennsylvania have developed a new, carbon-based nanoscale platform to electrically detect single DNA molecules.

TOPICS:

Monash Researchers Turn Fat Into Stem Cells

July 27, 2010 7:05 am | News | Comments

Australian scientists from the Monash Institute of Medical Research have reprogrammed adult mouse fat cells and neural cells to become stem cells that can differentiate into a variety of different cells, pluripotency.

TOPICS:

VARI Partners to Develop Phase 1 Cancer Program

July 27, 2010 6:57 am | News | Comments

Cancer patients in West Michigan will soon have the opportunity to access new drugs being developed to fight their disease due to a partnership being formed in Grand Rapids.

TOPICS:

Onyx Says Carfilzomib Results Promising

July 27, 2010 6:52 am | News | Comments

Onyx Pharmaceuticals Inc. reported positive clinical trial results for its cancer drug candidate, saying it worked for some multiple myeloma patients who have seen other therapies fail.

TOPICS:

Compound Decreases Metabolic Problems From Obesity

July 27, 2010 6:45 am | News | Comments

An experimental compound appears to improve metabolic abnormalities associated with obesity, according to a preliminary study led by researchers at the National Institutes of Health. A report of the study, which was conducted with obese mice, appears online in the Journal of Clinical Investigation.

TOPICS:

Merck Partnering With Sinopharm On Vax

July 27, 2010 6:33 am | News | Comments

Merck & Co. said it will team up with Sinopharm, a huge Chinese distributor and maker of pharmaceutical and other health products, to market vaccines and potentially other drugs.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading